Cargando…
Increased m(6)A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis
BACKGROUND: Gemcitabine is among the most commonly utilized chemotherapeutic agents for treating pancreatic cancer (PC), yet patients ultimately develop chemoresistance and thus exhibit a poor prognosis. Long noncoding RNAs (lncRNAs) can function as key regulators of PC progression and may serve as...
Autores principales: | Ye, Xin, Wang, Li-Ping, Han, Cong, Hu, Hao, Ni, Chen-Ming, Qiao, Guang-Lei, Ouyang, Liu, Ni, Jun-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011309/ https://www.ncbi.nlm.nih.gov/pubmed/35433957 http://dx.doi.org/10.21037/atm-22-556 |
Ejemplares similares
-
LncRNA Lnc712 Promotes Tumorigenesis in Hepatocellular Carcinoma by Targeting miR-142-3p/Bach-1 Axis
por: Cui, Dan, et al.
Publicado: (2020) -
Metformin suppresses lung adenocarcinoma by downregulating long non-coding RNA (lncRNA) AFAP1-AS1 and secreted phosphoprotein 1 (SPP1) while upregulating miR-3163
por: Qiu, Caiyu, et al.
Publicado: (2022) -
LncRNA HOXA‐AS3 promotes the malignancy of glioblastoma through regulating miR‐455‐5p/USP3 axis
por: Chen, Wanghao, et al.
Publicado: (2020) -
Long non-coding FAM201A accelerates the tumorigenesis and progression of colorectal cancer through miR-3163/MACC1 axis
por: Zeng, Lifeng, et al.
Publicado: (2022) -
lncRNA USP30-AS1 sponges miR-765 and modulates the progression of colon cancer
por: Li, Chengren, et al.
Publicado: (2022)